Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 827 of 1,261
  1. US 8664242

    8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  2. US 8663705

    Method and apparatus for producing a stabilized antimicrobial non-toxic electrolyzed saline solution exhibiting potential as a therapeutic

    Reoxcyn Discoveries Group, Inc. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  3. US 8664227

    Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents

    Theravance, Inc. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  4. US 8664219

    Aminopyrimidines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  5. US 8664177

    Peptide compositions and methods for treating patients

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  6. US 8663936

    Sodium channel protein type III α-subunit splice variant

    Vertex Pharmaceuticals Incorporated · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  7. US 8663694

    Taste masked dosage form containing roflumilast

    TAKEDA GMBH · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  8. US 8663683

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  9. US 8663681

    Oral dosage forms comprising progesterone and methods of making and using the same

    TEVA WOMEN'S HEALTH, INC. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  10. US 8663649

    Diagnosis and treatment of Trypanosoma cruzi infection and Chagas disease

    The Board of Regents of the University of Texas System · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  11. US 8663622

    Recombinant vaccine viruses expressing IL-15 and methods using the same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  12. US 8663633

    Protease screening methods and proteases identified thereby

    Catalyst Biosciences, Inc. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  13. US 8663624

    Adeno-associated virus virions with variant capsid and methods of use thereof

    The Regents of the University of California · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  14. US 8663703

    Drug microparticles, processes of preparing them and a drug delivery vehicle comprising them

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  15. US 8664238

    Indenoisoquinolinone derivatives, manufacturing method and medical use thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  16. US 8664220

    Polycyclic compounds as lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  17. US 8664212

    Diazo bicyclic Smac mimetics and the uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  18. US 8664193

    Compositions and methods for inhibiting expression of factor VII gene

    Alnylam Pharmaceuticals, Inc. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  19. US 8664254

    Dual-acting imidazole antihypertensive agents

    Theravance, Inc. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  20. US 8663987

    Mesenchymal stem cells for the treatment of CNS diseases

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  21. US 8663968

    Simian T-cell lymphotropic virus

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  22. US 8663950

    Production of a monoclonal antibody therapeutic against west nile virus in plants

    THE ARIZONA BOARD OF REGENTS · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  23. US 8664183

    SPANX-B polypeptides and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  24. US 8664273

    Treatment of hepatitis C virus with telaprevir (VX-950) in patients non-responsive to treatment with pegylated interferon-alpha 2A/2B and ribavirin

    Vertex Pharmaceuticals Incorporated · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.